Connection

Malik Peiris to Pandemics

This is a "connection" page, showing publications Malik Peiris has written about Pandemics.
Connection Strength

0.192
  1. What can we expect from first-generation COVID-19 vaccines? Lancet. 2020 11 07; 396(10261):1467-1469.
    View in: PubMed
    Score: 0.030
  2. Infection of dogs with SARS-CoV-2. Nature. 2020 10; 586(7831):776-778.
    View in: PubMed
    Score: 0.029
  3. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
    View in: PubMed
    Score: 0.029
  4. Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
    View in: PubMed
    Score: 0.026
  5. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
    View in: PubMed
    Score: 0.008
  6. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020 10 23; 371:m3862.
    View in: PubMed
    Score: 0.008
  7. Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020. Emerg Infect Dis. 2020 12; 26(12):3076-3078.
    View in: PubMed
    Score: 0.008
  8. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease. Emerg Infect Dis. 2020 11; 26(11):2701-2704.
    View in: PubMed
    Score: 0.007
  9. Antibody Profiles in Mild and Severe Cases of COVID-19. Clin Chem. 2020 08 01; 66(8):1102-1104.
    View in: PubMed
    Score: 0.007
  10. SARS-CoV-2 infection in conjunctival tissue - Authors' reply. Lancet Respir Med. 2020 07; 8(7):e58.
    View in: PubMed
    Score: 0.007
  11. Emergence of a novel human coronavirus threatening human health. Nat Med. 2020 03; 26(3):317-319.
    View in: PubMed
    Score: 0.007
  12. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
    View in: PubMed
    Score: 0.002
  13. Nowcasting epidemics of novel pathogens: lessons from COVID-19. Nat Med. 2021 03; 27(3):388-395.
    View in: PubMed
    Score: 0.002
  14. In-Flight Transmission of SARS-CoV-2. Emerg Infect Dis. 2020 11; 26(11):2713-2716.
    View in: PubMed
    Score: 0.002
  15. SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China. Emerg Infect Dis. 2020 12; 26(12):3071-3074.
    View in: PubMed
    Score: 0.002
  16. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
    View in: PubMed
    Score: 0.002
  17. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020 09 04; 369(6508):1210-1220.
    View in: PubMed
    Score: 0.002
  18. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.002
  19. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020 07; 583(7818):834-838.
    View in: PubMed
    Score: 0.002
  20. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020 07; 8(7):687-695.
    View in: PubMed
    Score: 0.002
  21. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020 06; 178:104786.
    View in: PubMed
    Score: 0.002
  22. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020 05; 26(5):676-680.
    View in: PubMed
    Score: 0.002
  23. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020 04 01; 66(4):549-555.
    View in: PubMed
    Score: 0.002
  24. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 06; 20(6):656-657.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.